文献速递胃肠外科围术期管理与 ERAS

较高EOSS评分与减重术后并发症及死亡独立相关:MBSAQIP分析

Higher Edmonton Obesity Staging System scores are independently associated with postoperative complications and mortality following bariatric surgery: an analysis of the MBSAQIP.
PubMed 文献 · Surg Endosc · 2020-11-05

基于MBSAQIP数据库2015-2017年430238例初次LSG或LRYGB患者,评估EOSS评分与30天主要术后并发症的关系。多变量logistic回归显示EOSS 2、3、4与主要并发症显著相关,EOSS 4相关性最强(OR 2.30),EOSS 3和4与死亡相关性最强。EOSS可用于患者分期并识别术后并发症高风险者。

要点

  • EOSS 4与30天主要并发症相关性最强(OR 2.30)。
  • LRYGB相比LSG与主要并发症相关性更强(OR 2.03)。
  • EOSS 3和4与死亡相关性最强。

核心结论

  • 较高EOSS评分与30天主要术后并发症和死亡率独立相关。
  • EOSS有助于对患者进行分期并识别术后并发症高风险者。

研究设计与样本

  • 回顾性队列分析,数据来自MBSAQIP注册库,纳入2015-2017年430238例初次LSG或LRYGB患者,79.4%为女性。
  • 根据数据库提取的合并症和功能限制分配EOSS评分,采用多变量logistic回归分析EOSS评分、年龄、性别、BMI、手术类型或手术时间与30天主要并发症的关系。

主要发现

  • 患者EOSS评分相对频率:0和1为23.9%,2为62.8%,3为10.5%,4为2.9%。
  • 术前平均BMI为45.4(SD 7.9)kg/m2,平均年龄为44.6(SD 12.0)岁。
  • 总体30天主要并发症率为3.5%。
  • EOSS 2、3、4与主要并发症显著相关,EOSS 4相关性最强(OR 2.30;95% CI 2.11-2.51,p < 0.001)。
  • LRYGB相比LSG与主要并发症相关性更强(OR 2.03;95% CI 1.97-2.11,p < 0.001)。

临床怎么用

  • 对于减重手术患者,可采用EOSS评分进行术前风险分层,识别术后并发症高风险者。
  • EOSS 4患者术后主要并发症风险显著增高,应加强围术期管理。
  • EOSS 3和4患者死亡风险较高,需重点关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Bariatric surgery is an evidence-based approach for sustained weight loss in patients with severe obesity. The most common procedures in North America are the laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB). The Edmonton Obesity Staging System (EOSS) is a tool that assigns patients a score of 0 to 4 according to their obesity-related comorbidities and functional status. Previous research demonstrates that increasing EOSS score is associated with overall non-operative mortality risk. OBJECTIVE: We sought to assess the association of the EOSS with major 30-day postoperative complications following LSG or LRYGB. METHODS: Primary LSG or LRYGB patients were identified from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program data registry. Patients were assigned EOSS scores according to their comorbidities and functional limitations extracted from the database. Multivariable logistic regression analysis was conducted to evaluate the relationship between EOSS score, age, sex, BMI, type of procedure, or operative time with 30-day major complications. RESULTS: From 2015 to 2017, 430,238 patients (79.4% female) who underwent primary LSG or LRYGB were identified. The relative frequencies of patients by EOSS score were: 0 and 1 (23.9%), 2 (62.8%), 3 (10.5%), and 4 (2.9%). Mean preoperative BMI was 45.4 (SD 7.9) kg/m2 and mean age was 44.6 (SD 12.0) years. The overall 30-day major complication rate was 3.5%. EOSS 2, 3, and 4 were significantly associated with major complications. The strongest associations with major complications were EOSS 4 (OR 2.30; 95% CI 2.11-2.51, p < 0.001) and LRYGB versus LSG (OR 2.03; 95% CI 1.97-2.11, p < 0.001). EOSS 3 and 4 were most strongly associated with death. CONCLUSION: Higher EOSS scores are independently associated with 30-day major postoperative complications and mortality. The EOSS provides utility in staging patients and identifying those at greater risk of postoperative complications.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Skulsky SL, Dang JT, Switzer NJ, et al. Higher Edmonton Obesity Staging System scores are independently associated with postoperative complications and mortality following bariatric surgery: an analysis of the MBSAQIP. Surg Endosc. 2020. PMID: 33155074. doi:10.1007/s00464-020-08138-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。